fbpx

Resources

Aug 14, 2023

Wet AMD Outcomes Through the Years

 

Wet AMD Outcomes Through the Years

Aug 8, 2023

Iveric Bio Receives U.S. FDA Approval for IZERVAY™ (avacincaptad pegol intravitreal solution), a New Treatment for Geographic Atrophy

NEWS PROVIDED BY Astellas Pharma Inc. 04 Aug 2023, 21:24 ET IZERVAY is the only approved GA treatment with a statistically significant reduction in the rate of GA progression at the 12-month…

Iveric Bio Receives U.S. FDA Approval for IZERVAY™ (avacincaptad pegol intravitreal solution), a New Treatment for Geographic Atrophy

Aug 1, 2023

HealthWell Foundation Opens New Financial Assistance Fund for People Diagnosed with Type 2 Diabetes

byPRNewswire Fund Helps Underinsured Americans in Need of Medication Copayment Assistance GERMANTOWN, Md., July 31, 2023 /PRNewswire/ — The HealthWell Foundation®, an independent non-profit that provides a financial lifeline for inadequately insured Americans,…

HealthWell Foundation Opens New Financial Assistance Fund for People Diagnosed with Type 2 Diabetes

Jul 31, 2023

Matters of Vision! 2023 Elk Grove, IL

Register today before they are gone- Only 11 seats remain for the August 12th program in Elk Grove, IL. Call (855) 962-2852

Matters of Vision! 2023 Elk Grove, IL

Jul 31, 2023

Minty Cucumber Salad

by: Beth Warren Beth Warren Nutrition <beth@bethwarrennutrition.com> MINTY WATERMELON CUCUMBER SALAD INGREDIENTS • 8 cups cubed seedless watermelon • 2 English cucumbers, halved lengthwise and sliced • 6 green onions,…

Minty Cucumber Salad

Jul 26, 2023

BREAKING NEWS: FDA approves XDEMVY for treatment of Demodex blepharitis

by: David Hutton According to Tarsus Pharmaceuticals, lotilaner ophthalmic solution 0.25% (XDEMVY) is the first approved therapeutic for Demodex blepharitis and has demonstrated efficacy across multiple clinical measures of the…

BREAKING NEWS: FDA approves XDEMVY for treatment of Demodex blepharitis

Jun 20, 2023

Geographic Atrophy new treatment

by: Pamela Weber, MD Island Retina We finally have a treatment for dry AMD with geographic atrophy “Syfovre”. It will be available soon, so call and schedule your appointment to see…

Geographic Atrophy new treatment

Jun 20, 2023

Understanding Age-Related Macular Degeneration

by Pamela Weber, MD Island Retina Dr. Weber guides you through AMD. What to look for, the different kinds and the facts, warning signs, and new state-of-the-art treatments. Dr. Weber…

Understanding Age-Related Macular Degeneration

Jun 13, 2023

Diabetes and Oral Health

A healthy mouth is important for everyone, but high blood sugar can make it harder to keep your mouth healthy. If you have diabetes, learn how you can avoid oral…

Diabetes and Oral Health

Jun 12, 2023

Macular Degeneration Association Upcoming programs

Upcoming Programs- Did you know that there are 15 million people with some form of macular degeneration? Please join one of the conferences in July to learn more. July program…

Macular Degeneration Association Upcoming programs

Jun 12, 2023

Ophthalmology 360® Virtual Summit Series

Description: The Ophthalmology 360® Virtual Summit Series provides 2 days of accredited education and an excellent opportunity to learn from key opinion leaders in the eye care field, who will discuss the latest advances…

Ophthalmology 360® Virtual Summit Series

May 29, 2023

Memorial Day 2023

All Gave Some- Some Gave All

Memorial Day 2023

Apr 13, 2023

ICYMI: Study finds Americans over the age of 40 lack sight-saving knowledge of AMD

by: David Hutton A new survey of Americans 40 and older reveals a concerning lack of knowledge about the leading cause of blindness and vision loss among older adults, age-related…

ICYMI: Study finds Americans over the age of 40 lack sight-saving knowledge of AMD

Apr 13, 2023

Know About The Health Benefits Of Prunes

Four to five prunes a day provide approximately 280 mg of potassium or about 12% of your daily required requirement. By: ABP News Bureau New Delhi: Prunes, sometimes known as dried plums,…

Know About The Health Benefits Of Prunes

Apr 13, 2023

Target ‘Inflammaging’ to Promote Healthy Aging

by: April 11, 2023 / By Julie Poteet, OD, MS, CNS, FONS Doctors are taught that there are two types of inflammation, acute and chronic. Acute inflammation is characterized by short duration…

Target ‘Inflammaging’ to Promote Healthy Aging

Mar 15, 2023

Seeing Clearly

By Claire Zulkey How a routine vision check can save your life Jackie Memije assumed she was just stressed out, so she ignored her symptoms. The whooshing in the ears,…

Seeing Clearly

Mar 15, 2023

How Melatonin Might Impact Your Eye Health

BY BETH BRADFORD Melatonin works in your brain to regulate your sleep cycle because it kicks in when there’s less light. Although your body produces it naturally, many of us take…

How Melatonin Might Impact Your Eye Health

Mar 15, 2023

LumiThera Announces Sustained Vision Improvement for 24 months in Dry Age-Related Macular Degeneration Subjects from US LIGHTSITE III Clinical Trial Data

Press Release March 15, 2023, 07:17 AM Eastern Daylight Time SEATTLE–(BUSINESS WIRE)–LumiThera Inc., a medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the 24-…

LumiThera Announces Sustained Vision Improvement for 24 months in Dry Age-Related Macular Degeneration Subjects from US LIGHTSITE III Clinical Trial Data

Mar 14, 2023

Ocugen submits NDA with FDA to initiate phase 1 clinical trial evaluating OCU200 for treatment of DME

by: David Hutton The regulatory milestone fulfills the company’s goal to file the IND for OCU200 within the first quarter of 2023. Ocugen Inc. today announced that it has submitted…

Ocugen submits NDA with FDA to initiate phase 1 clinical trial evaluating OCU200 for treatment of DME

Mar 7, 2023

MacuHealth & Macular Degeneration Association announce partnership

Press Release  The Macular Degeneration Association and MacuHealth Announce Partnership   BIRMINGHAM, Mich., March 07, 2023 – The Macular Degeneration Association, an organization dedicated to educating age-related macular degeneration (AMD)…

MacuHealth & Macular Degeneration Association announce partnership

Mar 7, 2023

Eyedaptic unveils the EYE5 glasses with EyeSwitch™

The latest model in the Eyedaptic product showcase boasts comfort without sacrificing usability and adds brand-new artificial intelligence features. Laguna Hills, CA — October 24, 2022 —Eyedaptic, Inc., is excited to…

Eyedaptic unveils the EYE5 glasses with EyeSwitch™

Feb 28, 2023

February as Low Vision and Age-Related Macular Degeneration (AMD) Awareness Month.

These conditions impact millions (AMD alone affects 196M) of individuals worldwide. This month highlights the importance of those with low vision seeking the appropriate care and management. Low Vision FAQ My…

February as Low Vision and Age-Related Macular Degeneration (AMD) Awareness Month.

Feb 28, 2023

AFLIBERCEPT 8 MG BLA FOR TREATMENT OF WET AGE-RELATED MACULAR DEGENERATION AND DIABETIC MACULAR EDEMA ACCEPTED FOR FDA PRIORITY REVIEW

Breaking News BLA supported by two pivotal trials demonstrating non-inferior vision gains to EYLEA® (aflibercept) Injection, with vast majority of patients maintaining extended dosing regimens through 48 weeks If approved, aflibercept…

AFLIBERCEPT 8 MG BLA FOR TREATMENT OF WET AGE-RELATED MACULAR DEGENERATION AND DIABETIC MACULAR EDEMA ACCEPTED FOR FDA PRIORITY REVIEW

Feb 22, 2023

Researchers identify a new genetic risk factor for age-related macular degeneration

Reviewed by Emily Henderson, B.SC. Researchers at Tel Aviv University identified a new genetic risk factor for the complex eye disease AMD (Age-related Macular Degeneration), a leading cause for loss…

Researchers identify a new genetic risk factor for age-related macular degeneration

Feb 19, 2023

FDA Approves Apellis’ SYFOVRE™, for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

Newly approved treatment for Geographic Atrophy by FDA Geographic atrophy (GA) is the advanced form of dry age-related macular degeneration (AMD) which causes blindness in one million people in the…

FDA Approves Apellis’ SYFOVRE™, for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

Feb 13, 2023

February is AMD Awareness & Low Vision Month

  Here are some helpful tips to help.   1. Speak to your eye care professional to see if there are any new treatments available. 2. If you have lost…

February is AMD Awareness & Low Vision Month

Feb 13, 2023

AMD-See the Day

New services available at CVS in Tampa, FL Don’t let age dim your vision. As we age, our eyes change, but not all changes are “natural” or inevitable-Related Macular Degeneration,…

AMD-See the Day

Feb 9, 2023

FDA grants fast track designation for retinitis pigmentosa treatment

EA-2353 for the treatment of retinitis pigmentosa received fast-track designation from the FDA, according to a press release from Endogena Therapeutics. The gene-independent treatment approach activates endogenous retinal stem and progenitor…

FDA grants fast track designation for retinitis pigmentosa treatment

Feb 7, 2023

February is Macular Degeneration & Low Vision Awareness month

Low vision looks different for everyone — literally. These are four examples of what blindness can look like. Blindness is a spectrum, it is rarely absolute, and understanding the low…

February is Macular Degeneration & Low Vision Awareness month

Jan 25, 2023

More Than 1 in 4 Americans Over 70 Has Impaired Vision

by: Dennis Thompson Key Takeaways More than a quarter of U.S. seniors is living with an untreated vision problem — nearsightedness, farsightedness, or impaired contrast sensitivity Trouble reading? This can…

More Than 1 in 4 Americans Over 70 Has Impaired Vision

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.